Search all trials

Find therapies in clinical trials near you – page 42

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Follicular lymphoma+2

Not recruiting

InvestigationalNo placebo

Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Mosunetuzumab

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Pleural mesothelioma malignant

Not recruiting

Registered drugNo placebo

Study of Nivolumab, Ipilimumab, and UV1 Vaccine for Patients with Malignant Pleural Mesothelioma After Initial Chemotherapy

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Alrefimotide

Contact Research Centre

Systemic mastocytosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide

Contact Research Centre

Factor VIII deficiency

Not recruiting

InvestigationalNo placebo

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

InvestigationalNo placebo

Norway

Participants:0–17 years · 18–64 years · 65+ years
Substances:Efanesoctocog Alfa

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Zilovertamab Vedotin

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Registered drug

Norway

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational

Norway

Participants:18–64 years · 65+ years
Substances:Spesolimab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Endometrial cancer

Not recruiting

Registered drug

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Loperamide

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Investigational

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Investigational

Norway

Participants:65+ years
Substances:Xevinapant

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Lenvatinib

Contact Research Centre

Find therapies in clinical trials near you – page 42

527 trials match your criteria

Follicular lymphoma+2

Study of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma

Neoplasm

Study of Pembrolizumab for Patients with Advanced Solid Tumors

Pleural mesothelioma malignant

Study of Nivolumab, Ipilimumab, and UV1 Vaccine for Patients with Malignant Pleural Mesothelioma After Initial Chemotherapy

Systemic mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Factor VIII deficiency

Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

Diffuse large B-cell lymphoma

Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Malignant melanoma

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Hidradenitis

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Hepatocellular carcinoma

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Endometrial cancer

Study of Navtemadlin as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Squamous cell carcinoma of head and neck

Study on Radiotherapy with Xevinapant or Placebo for Older Patients with Advanced Head and Neck Cancer

Hepatocellular carcinoma

Study of Pembrolizumab and Lenvatinib with TACE for Patients with Incurable Non-metastatic Liver Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.